WELCOME TO THE BRITISH ASSOCIATION FOR THE STUDY OF THE LIVER
Three afternoons of multi-professional liver learning
Dates: 29-30th April & 1st May
Time: 13:00-16:30 each day
Multi-professional, topic-focused education with attractive rates.
Register: Here
Programme: Here
BASL ANNUAL MEETING
7th-10th October 2025
BASL ANNUAL MEETING 2025 - Tues 7th - Fri 10th October
Including: BLTG Transplant Meeting 7th & 8th (am) October
BLNA Nurse meeting 8th (pm) and 9th October
Venue: International Convention Centre, Belfast
Abstract Submission Open! Registration Open!
Visit the Conference website for full details > HERE
BASL AND BASL SUB-GROUPS
 |
The British Association for the Study of the Liver is a multi-disciplinary society with around 900 members composed of interested individuals from clinical medicine, clinical and basic research and allied professions. |
 |
British Liver Nurses' Association is a professional nursing organisation aiming to develop knowledge and understanding of liver disease, in order to improve the quality of patient care. |
 |
The British Viral Hepatitis Group aims to improve the management and study of patients with chronic viral liver disease, bringing together UK hepatologists, gastroenterologists, infectious disease physicians, virologists and interested epidemiologists. |
 |
The BLTG (British Liver Transplant Group) was launched in 2014 to represent the professional interests of liver transplantation in the UK and promote strategic and academic development. The BLTG will foster close relationships with BTS (British Transplant Society) and LICAGE (Liver Intensive Care Group of Europe) and will build on the role of the UK and Ireland Annual Meeting by delivering structure and authority to the group. |
 |
Is a professional pharmacy organisation aiming to develop knowledge and understanding of liver disorders including viral hepatitis, in order to improve the quality of patient care, through medicines optimisation, collaborative and multi-disciplinary working and promoting patient-focused research. |
 |
British Association for Allied Health Professionals in Liver is a professional group for AHP’s specialising or working with patients with liver conditions. Bringing together specialist hepatology AHP’s from across the four Nations. Their aim is to promote excellence through the provision of AHP care to all patients with liver disorders. |
News
Decompensated Cirrhosis - an update of the BSG/BASL admission care bundle
Read moreDecompensated cirrhosis: an update of the BSG/BASL admission care bundle.
View the open access paper on the Frontline Gastroenterology website here > Decompensated cirrhosis: an update of the BSG/BASL admission care bundle | Frontline Gastroenterology
Decompensated Cirrhosis Care Bundle - First 6 hour
Download a copy here: Download Decompensated Cirrhosis Care Bundle 13-1-25.docx
NB: if you are using Chrome and the document fails to open click > Here
or contact admin@basl.org.uk to request a word version.
The James Lind Alliance - Survey: Priorities for Liver Cirrhosis Research
Read moreThe James Lind Alliance survey to prioritise unanswered research questions for liver cirrhosis is now open.
Whether you're a healthcare professional, patient, carer, family member, or researcher, all opinions matter.
What do you think are the priorities for liver cirrhosis research?
We are asking you to select the questions you think are important from a list of 38 possible research questions, then from your long list, choose your top 10 most important questions.
We also ask you to give some information about yourself so that we will know if the survey is reaching a wide audience and to help us target groups wherethere are a low number of responses. You can choose not to answer these questions.
The survey should only take 10 – 15 minutes.
Take the survey: https://www.surveymonkey.com/r/SMMF6XJ
Closes: May 2nd 2025
European Network for the Study of Cholangiocarcinoma - Delphi consensus study on artificial intelligence for biliary tract cancer - Survey
Read moreThe European Network for the Study of Cholangiocarcinoma is currently performing a Delphi consensus study on artificial intelligence for biliary tract cancers.
We are seeking clinicians, researchers, patients, industrial representatives, and regulatory professionals to participate in a quick survey to tell us about their perceptions and concerns about AI in this cancer.
Our survey will open on April 9th (first day of Cholangiocarcinoma Foundation annual meeting in USA) and close on May 9th (final day of AMMF Cholangiocarcinoma Charity annual meeting in UK).
Please find the QR code in the poster below and a link to the survey here: https://www.surveymonkey.com/r/CGRMDVS
FSRH guideline development - request for help with securing liver disease topic expert
Read moreThe FSRH Clinical Effectiveness Unit is currently updating their guideline on the safety of contraceptive methods (the UKMEC). The UKMEC considers safety of use of contraceptive methods by individuals with a variety of personal characteristics or medical conditions: UK Medical Eligibility Criteria for Contraceptive Use.
They would like to secure some input from a liver disease expert to advise their Guideline Development Group and they would be very grateful for any help BASL members can give if someone is willing to assist them.
They are seeking a topic expert with a broad knowledge of liver disease who could advise our Guideline Development Group on the following areas:
- Cholestasis
- Viral hepatitis
- Cirrhosis
- Liver tumours
It would involve an initial meeting with their Clinical Director and systematic reviewer to consider the evidence (about an hour) in April/early May. They would also ask the topic expert to attend, if possible, part of their UKMEC Guideline Development Group meeting, which is taking place on the afternoon of Monday 9 June 2025 (for a slot of about 1 hour). They would also ask the expert to review relevant sections of draft text for the guideline subsequently, if it is agreed that revisions are needed.
Participating in this project offers an opportunity to work with leading UK and international experts on national guidance as well as those from other specialties, gain experience in guideline development and be acknowledged for your contribution in the final guideline document.
The topic expert must be a consultant clinician currently working in the specified field. The topic expert must also be in good standing with the relevant professional body and not subject to fitness to practise proceedings. Previous experience in the development of guidelines would be welcome but is not essential.
Please note the role isn’t remunerated.
They would be delighted if one of our members would be able to help.
If you are interested in assisting please contact: ceu@fsrh.org .
Inviting healthcare professionals who treat or support transplant patients
Read moreThere are challenges that are unique to female patients as they go through the organ transplant process. A research team at the University of Edinburgh are carrying out a study, funded by NHS Blood and Transplant, to gain a greater understanding of their experiences and needs at different stages of this process and identify where and how improvements can be made to address these.
They are inviting healthcare professionals who treat or support transplant patients to express interest in participating in an online workshop. At the workshop, they will present findings from their qualitative survey on female transplant patients' experiences and needs, asking staff to work together to discuss the findings and identify key priority areas for action to ensure that these are addressed to improve the experience for female patients.
Please click on the link below to find out more about the study and what is involved in taking part:
https://app.onlinesurveys.jisc.ac.uk/s/edinburgh/workshop-for-transplant-staff
Events
BASL X-tra is an online educational conference.
Three afternoons of multi-professional liver learning on Tuesday 29th and Wednesday 30th April, and Thursday 1st May from 13:00-16:30 each day.
BASL X-tra will have something for everyone - multi-professional, topic-focused education delivered online with attractive rates.
Catch up Available - if you are not able to attend when the sessions are live, but still want to benefit from the event, please do still register as you will then be able to watch the sessions online and for 28 days later
29th April - Session 1: Immune Mediated Liver Disease
30th April - Session 2: Optimising Health in People with Decompensated Cirrhosis - joint BASL/BLNA
1st May - Session 3: Liver Grand-rounds: Complex and Controversial Cases
View the programme: Download BASL Xtra_programme_website_v7.pdf
Registration from just £20 for members:
From £20 for nurses, pharmacists, AHPs, students and scientists
From £50 for trainees
From £75 for consultants
CPD applied for
Contact conference@basl.org.uk for any queries.
06/05/25
Date: 6 May 2025
Time: 9:00-17:30 CEST
This one-day consensus conference is taking place the day before EASL Congress 2025 in Amsterdam.
Organised by EASL, AASLD, ASCO and ILCA
Join us for a high-impact, one-day event dedicated to redefiningclinical trial design and end-points in HCC.Building on recent breakthroughs, we will focus on what trulydefines clinical benefit, set new standards for upcoming Phase IIItrials, and explore innovative regulatory strategies
Registration
Registration is required to attend the pre-congress event “Trial design and end-points in HCC”.
Registration fee: EUR 102.85 (EUR 85 plus 21% Dutch VAT)
Visit the EASL Congress website to register > https://www.easlcongress.eu/2025-consensus-conference-hcc/
Flyer: Download HCC_Trial_design_conference_EASL_May_6th_2025.pdf
AMMF’s 2025 cholangiocarcinoma (CCA) conference will be held at the Radisson Blu Hotel, right beside London Stansted air and rail terminal, 07-09 May 2025.
This year, AMMF is delighted to welcome Dr Heinz-Josef Klümpen and Ms Rachel Guest, two internationally renowned specialists at the forefront of the CCA world, to co-chair the conference.
Under the theme, ‘Rethinking Liver Cancer – for a Fairer Deal, Faster’, the co-chairs will bring together an international faculty of some 40 speakers, who will explore the challenges faced and the advances made in the UK, Europe and beyond in the understanding of CCA, together with the importance of accelerating the progress we are now seeing.
To register for this event in person or virtually, and for venue and accommodation information, please click here
AMMF HPB Nurse Study Day – 07 May 2025
Running alongside the patient at carer sessions on day one of AMMF’s 2025 annual conference, we are hosting a study day with our Clinical Nurse Specialist (CNS) Advisory Board and extended international network of hepatobiliary (HPB) nurses. This event will provide a valuable opportunity to harness the collective expertise and first-hand experiences of the participating nurses.
Please note: This study day is intended for registered nurses only, for in person attendance. It will not be available to the virtual audience.
For further information, and details on how to register, please click here
Date: 7-10 May
Venue: Amsterdam, the Netherlands
Visit the Congress website for all the details; https://www.easlcongress.eu/
BVHG are happy to be an endorser of the European Meeting on HIV & Hepatitis 2025.
Founded more than twenty years ago, this meeting has evolved to embrace all aspects of the clinical care of people living with HIV in Europe. Particular emphasis is placed on optimal treatment strategies, clinical virology, molecular epidemiology, and public health aspects of HIV, HBV, HCV, as well as emerging viruses throughout Europe.
Meeting Details:
Date: 4-6 June 2025
Format: in-person (no virtual option available)
Location: Barcelona, Spain
Venue: Hotel Catalonia Barcelona Plaza
The Standard Fee Registration Deadline ends on Friday, 4 April 2025 at 23:59 CEST.
For more information on how to register for the meeting visit the event website here: https://academicmedicaleducation.com/meeting/23rd-european-meeting-hiv-hepatitis-2025
Quick Links
